T. Rowe Price Associates
INSM icon

T. Rowe Price Associates’s Insmed INSM Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.13B Sell
11,230,705
-1,692,836
-13% -$170M 0.13% 153
2025
Q1
$986M Buy
12,923,541
+219,131
+2% +$16.7M 0.12% 169
2024
Q4
$877M Buy
12,704,410
+123,429
+1% +$8.52M 0.1% 185
2024
Q3
$918M Buy
12,580,981
+417,613
+3% +$30.5M 0.11% 179
2024
Q2
$815M Buy
12,163,368
+1,394,002
+13% +$93.4M 0.1% 188
2024
Q1
$292M Buy
10,769,366
+5,595
+0.1% +$152K 0.04% 360
2023
Q4
$334M Buy
10,763,771
+356,555
+3% +$11M 0.04% 320
2023
Q3
$263M Buy
10,407,216
+234,920
+2% +$5.93M 0.04% 339
2023
Q2
$215M Buy
10,172,296
+190,232
+2% +$4.01M 0.03% 382
2023
Q1
$170M Buy
9,982,064
+4,153
+0% +$70.8K 0.03% 406
2022
Q4
$199M Buy
9,977,911
+429,664
+4% +$8.58M 0.03% 379
2022
Q3
$206M Sell
9,548,247
-6,674,376
-41% -$144M 0.03% 355
2022
Q2
$320M Buy
16,222,623
+364,362
+2% +$7.19M 0.04% 366
2022
Q1
$373M Buy
15,858,261
+537,057
+4% +$12.6M 0.04% 388
2021
Q4
$417M Buy
15,321,204
+580,772
+4% +$15.8M 0.04% 380
2021
Q3
$406M Buy
14,740,432
+367,747
+3% +$10.1M 0.04% 382
2021
Q2
$409M Buy
14,372,685
+3,070,140
+27% +$87.4M 0.04% 376
2021
Q1
$385M Buy
11,302,545
+1,650,241
+17% +$56.2M 0.04% 384
2020
Q4
$321M Buy
9,652,304
+153,054
+2% +$5.1M 0.03% 408
2020
Q3
$305M Sell
9,499,250
-68,049
-0.7% -$2.19M 0.04% 393
2020
Q2
$263M Buy
9,567,299
+2,590,890
+37% +$71.4M 0.03% 414
2020
Q1
$112M Buy
6,976,409
+445,634
+7% +$7.14M 0.02% 542
2019
Q4
$156M Sell
6,530,775
-266,353
-4% -$6.36M 0.02% 537
2019
Q3
$120M Sell
6,797,128
-260,839
-4% -$4.6M 0.02% 571
2019
Q2
$181M Sell
7,057,967
-827,528
-10% -$21.2M 0.03% 489
2019
Q1
$229M Sell
7,885,495
-790,903
-9% -$23M 0.03% 430
2018
Q4
$114M Sell
8,676,398
-1,823,846
-17% -$23.9M 0.02% 572
2018
Q3
$212M Sell
10,500,244
-1,999,246
-16% -$40.4M 0.03% 472
2018
Q2
$296M Sell
12,499,490
-80,791
-0.6% -$1.91M 0.05% 379
2018
Q1
$283M Sell
12,580,281
-448,341
-3% -$10.1M 0.05% 379
2017
Q4
$406M Buy
13,028,622
+168,938
+1% +$5.27M 0.07% 305
2017
Q3
$401M Buy
12,859,684
+2,565,133
+25% +$80.1M 0.07% 296
2017
Q2
$177M Sell
10,294,551
-513,668
-5% -$8.81M 0.03% 466
2017
Q1
$189M Buy
10,808,219
+301,294
+3% +$5.28M 0.04% 433
2016
Q4
$139M Buy
10,506,925
+469,053
+5% +$6.21M 0.03% 506
2016
Q3
$146M Buy
10,037,872
+27,350
+0.3% +$397K 0.03% 491
2016
Q2
$98.7M Buy
10,010,522
+365,441
+4% +$3.6M 0.02% 566
2016
Q1
$122M Buy
9,645,081
+368,935
+4% +$4.67M 0.03% 504
2015
Q4
$168M Buy
9,276,146
+234,757
+3% +$4.26M 0.04% 436
2015
Q3
$168M Buy
9,041,389
+387,762
+4% +$7.2M 0.04% 448
2015
Q2
$211M Buy
8,653,627
+282,480
+3% +$6.9M 0.04% 431
2015
Q1
$174M Buy
8,371,147
+7,940,960
+1,846% +$165M 0.04% 462
2014
Q4
$6.66M Buy
430,187
+29,187
+7% +$452K ﹤0.01% 1422
2014
Q3
$5.23M Buy
+401,000
New +$5.23M ﹤0.01% 1448
2014
Q2
Sell
-70,028
Closed -$1.33M 2539
2014
Q1
$1.33M Buy
+70,028
New +$1.33M ﹤0.01% 1631